查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1477352

狗疫苗市場 - 全球產業規模、佔有率、趨勢、機會和預測，按類型、疾病類型、給藥途徑、組成區域和競爭細分，2019-2029F

Dog Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Disease Type, By Route of Administration, By Component Region and Competition, 2019-2029F
出版日期: | 出版商: TechSci Research | 英文 183 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2023 年全球狗疫苗市場估值為14.5 億美元，預計在預測期內將強勁成長，到2029 年複合年成長率為5.75%。的推動：犬類疾病的日益普及、寵物擁有率的上升以及寵物主人對其毛茸茸的伴侶採取預防性醫療措施重要性的認知不斷增強。

市場概況
預測期 2025-2029
2023 年市場規模 14.5億美元
2029 年市場規模 20.3億美元
2024-2029 年複合年成長率 5.75%
成長最快的細分市場 犬傳染性呼吸道疾病綜合體 (CIRDC)
最大的市場 北美洲

由於狗容易感染狂犬病、細小病毒、犬瘟熱和犬流感等一系列傳染病，因此對保護它們免受這些疾病的疫苗的需求激增。嚴格的政府法規進一步強化了這一趨勢，政府法規強制要求對某些疾病進行疫苗接種，以控制疫情並保障公眾健康。此外，獸醫學和生物技術的進步促進了更有效、更安全的疫苗的開發，推動了市場的擴張。此外，伴侶動物醫療保健產業的不斷擴大，加上新興經濟體可支配收入水準的提高，刺激了對包括疫苗在內的寵物醫療保健產品的投資。

該市場的特點是針對不同疾病、給藥途徑和免疫持續時間的疫苗種類繁多，為寵物主人和獸醫提供了多種選擇，以滿足個人需求。此外，DNA 疫苗、重組疫苗和口服疫苗等新型疫苗遞送技術的出現預計將徹底改變疫苗領域，提高功效、易於給藥並減少副作用。從地理上看，北美和歐洲由於寵物收養率高、寵物醫療基礎設施完善以及監管框架強大，在全球狗疫苗市場佔據主導地位。然而，由於寵物數量的迅速成長、城市化進程的加快以及人們對寵物健康和保健意識的不斷提高，亞太地區有望實現大幅成長。市場參與者正專注於產品創新、合作夥伴關係和併購等策略性舉措，以獲得競爭優勢並擴大其在全球狗疫苗市場的影響力。

主要市場促進因素

寵物擁有率上升

犬類疾病的盛行率不斷增加

強制接種疫苗的政府法規

主要市場挑戰

寵物主人對疫苗猶豫不決

消費者對價格的敏感度

主要市場趨勢

疫苗開發的技術進步

專注於預防保健

細分市場洞察

疾病類型見解

組件洞察

區域洞察

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第 4 章：全球狗疫苗市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型（改良/減毒活、去活化（去活化）、其他）
    • 依疾病類型（犬瘟熱、犬傳染性呼吸道疾病症候群（CIRDC）、犬小病毒病/細小病毒病、犬鉤端螺旋體病、犬萊姆病、犬傳染性肝炎、犬狂犬病、其他疾病）
    • 依給藥途徑（注射、鼻內、口服）
    • 按成分（聯合疫苗、單一疫苗）
    • 按地區
    • 按公司分類 (2023)
  • 市場地圖
    • 按類型
    • 依疾病類型
    • 依給藥途徑
    • 按組件
    • 按地區

第 5 章：亞太地區狗疫苗市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型
    • 依疾病類型
    • 依給藥途徑
    • 按組件
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 澳洲
    • 日本
    • 韓國

第 6 章：歐洲狗疫苗市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型
    • 依疾病類型
    • 依給藥途徑
    • 按組件
    • 按國家/地區
  • 歐洲：國家分析
    • 法國
    • 德國
    • 西班牙
    • 義大利
    • 英國

第 7 章：北美狗疫苗市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型
    • 依疾病類型
    • 依給藥途徑
    • 按組件
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第 8 章：南美狗疫苗市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型
    • 依疾病類型
    • 依給藥途徑
    • 按組件
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 9 章：中東和非洲狗疫苗市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型
    • 依疾病類型
    • 依給藥途徑
    • 按組件
    • 按國家/地區
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 埃及

第 10 章：市場動態

  • 促進要素
  • 挑戰

第 11 章：市場趨勢與發展

  • 最近的發展
  • 產品發布
  • 併購

第 12 章：全球狗疫苗市場：SWOT 分析

第 13 章：波特的五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第14章：競爭格局

  • Bioveta AS
  • Hester Biosciences Limited
  • Boehringer Ingelheim International GmbH
  • Brilliant Bio Pharma Private Limited
  • Heska Corporation
  • Merck & Co., Inc.
  • Virbac SACA
  • Zendal Group
  • Elanco Animal Health Inc
  • Zoetis Services LLC.

第 15 章：策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 23817

Global Dog Vaccine Market was valued at USD 1.45 Billion in 2023 and is anticipated to project robust growth in the forecast period with a CAGR of 5.75% through 2029. The global dog vaccine market has experienced significant growth in recent years, fueled by several factors including the increasing prevalence of canine diseases, rising pet ownership rates, and a growing awareness among pet owners regarding the importance of preventive healthcare measures for their furry companions.

Market Overview
Forecast Period2025-2029
Market Size 2023USD 1.45 Billion
Market Size 2029USD 2.03 Billion
CAGR 2024-20295.75%
Fastest Growing SegmentCanine Infectious Respiratory Disease Complex (CIRDC)
Largest MarketNorth America

As dogs are susceptible to a range of infectious diseases such as rabies, parvovirus, distemper, and canine influenza, the demand for vaccines to protect them against these ailments has surged. This trend is further bolstered by stringent government regulations mandating vaccination against certain diseases to control outbreaks and safeguard public health. Moreover, advancements in veterinary medicine and biotechnology have led to the development of more efficacious and safer vaccines, driving market expansion. Additionally, the expanding companion animal healthcare sector, coupled with increasing disposable income levels in emerging economies, has spurred investment in pet healthcare products including vaccines.

The market is characterized by a diverse range of vaccines catering to various diseases, administration routes, and duration of immunity, offering pet owners and veterinarians a wide array of options to suit individual needs. Furthermore, the advent of novel vaccine delivery technologies such as DNA vaccines, recombinant vaccines, and oral vaccines is anticipated to revolutionize the landscape, offering improved efficacy, ease of administration, and reduced side effects. Geographically, North America and Europe dominate the global dog vaccine market owing to the high pet adoption rates, well-established pet healthcare infrastructure, and strong regulatory frameworks. However, the Asia-Pacific region is poised for substantial growth due to the burgeoning pet population, increasing urbanization, and rising awareness regarding pet health and wellness. Market players are focusing on strategic initiatives such as product innovation, partnerships, and mergers and acquisitions to gain a competitive edge and expand their presence in the global dog vaccine market.

Key Market Drivers

Rising Pet Ownership Rates

Rising pet ownership rates are a significant driver behind the growth of the global dog vaccine market. Across the world, there has been a notable increase in the number of households welcoming dogs as cherished members of their families. This trend can be attributed to various factors, including changing lifestyles, increased urbanization, and growing awareness of the benefit of pet companionship.

As more people choose to share their lives with dogs, the importance of ensuring their health and well-being becomes paramount. Pet owners are increasingly recognizing the need for preventive healthcare measures to safeguard their furry companions from a range of potential health risks, including infectious diseases. Vaccination plays a crucial role in protecting dogs from such diseases, making it an essential aspect of responsible pet ownership.

With the rise in pet ownership rates, the demand for dog vaccines has surged. Pet owners are actively seeking out veterinary services to ensure that their dogs receive the necessary vaccinations to stay healthy and protected. This increased demand for dog vaccines is driving growth in the global market, as veterinary clinics and healthcare providers strive to meet the needs of their growing client base.

Furthermore, the emotional bond between pet owners and their dogs often motivates them to prioritize their pets' health and well-being. Many pet owners view their dogs as beloved members of the family and are willing to invest in their care to ensure a long and happy life together. This sentiment contributes to the sustained demand for dog vaccines, as pet owners seek to provide the best possible protection for their canine companions.

Additionally, the growing trend of humanization of pets has led to a greater emphasis on preventive healthcare for dogs. Pet owners increasingly view their dogs as integral members of the family, deserving of the same level of care and attention as any other family member. This shift in attitude has translated into increased spending on pet healthcare products and services, including vaccinations, further driving growth in the global dog vaccine market.

Increasing Prevalence of Canine Diseases

The increasing prevalence of canine diseases is a significant driver behind the growth of the global dog vaccine market. Dogs are susceptible to a variety of infectious diseases, including rabies, parvovirus, distemper, and canine influenza, among others. These diseases can have serious health consequences for dogs, ranging from mild illness to severe complications and even death. As such, there is a growing recognition among pet owners and veterinarians of the importance of preventive measures, such as vaccination, to protect dogs from these health risks.

The prevalence of canine diseases varies depending on factors such as geographic location, environmental conditions, and population density. However, outbreaks of infectious diseases can occur in any region, posing a threat to the canine population. In recent years, there has been an uptick in reported cases of certain canine diseases in various parts of the world, driving concerns about the spread of these illnesses and the need for effective preventive measures.

In response to the increasing prevalence of canine diseases, there has been a corresponding rise in demand for dog vaccines. Vaccination is widely recognized as one of the most effective ways to prevent the spread of infectious diseases and protect dogs from illness. Pet owners are increasingly seeking out veterinary services to ensure that their dogs are up to date on their vaccinations, in order to minimize the risk of exposure to infectious agents.

Moreover, veterinarians play a crucial role in educating pet owners about the importance of vaccination and recommending appropriate vaccination schedules based on factors such as the dog's age, health status, and lifestyle. This proactive approach to preventive healthcare has contributed to the growing adoption of vaccination among pet owners, further boosting the demand for dog vaccines. Additionally, government agencies and public health organizations often implement vaccination programs targeting specific canine diseases, particularly those with zoonotic potential (i.e., diseases that can be transmitted from animals to humans). These programs aim to control the spread of infectious diseases within the canine population and mitigate the risk of transmission to humans. Compliance with government-mandated vaccination requirements is therefore another factor driving the demand for dog vaccines in many regions.

Government Regulations Mandating Vaccination

Government regulations mandating vaccination play a crucial role in boosting the global dog vaccine market. Across the world, governments recognize the importance of preventive healthcare measures in controlling the spread of infectious diseases among animals, including dogs. As such, they have implemented stringent regulations requiring pet owners to vaccinate their dogs against certain diseases, often as a condition of pet ownership or as part of public health initiatives.

These regulations serve several purposes. They aim to protect the health and well-being of dogs by minimizing the risk of exposure to infectious agents. Vaccination helps to stimulate the dog's immune system to produce protective antibodies against specific diseases, thereby reducing the likelihood of illness and its associated complications. By mandating vaccination, governments seek to ensure that dogs receive essential protection against

Government-mandated vaccination requirements help to control the spread of infectious diseases within the canine population. Vaccinated dogs are less likely to become infected with and transmit diseases to other dogs, thereby reducing the incidence and severity of outbreaks. This not only benefits individual dogs but also contributes to the broader goal of disease control and eradication within communities and regions.

Moreover, government regulations mandating vaccination serve to safeguard public health by reducing the risk of transmission of zoonotic diseases from dogs to humans. Many canine diseases have the potential to infect humans, either directly or indirectly, posing a public health threat. By ensuring high vaccination coverage among dogs, governments can mitigate the risk of zoonotic disease transmission, protecting both human and animal populations from harm.

Compliance with government-mandated vaccination requirements is essential for pet owners, as failure to vaccinate their dogs may result in legal consequences, such as fines or restrictions on pet ownership. This regulatory enforcement encourages pet owners to prioritize vaccination as part of their responsibility towards their pets' health and well-being.

Key Market Challenges

Vaccine Hesitancy Among Pet Owners

Vaccine hesitancy among pet owners presents a significant challenge to the global dog vaccine market. Some pet owners may be reluctant to vaccinate their dogs due to concerns about vaccine safety, efficacy, or potential side effects. This hesitancy can stem from misinformation or misconceptions about vaccines, as well as personal beliefs or experiences.

Addressing vaccine hesitancy requires effective communication and education initiatives to provide accurate information about the importance of vaccination in protecting dogs from infectious diseases. Veterinary professionals play a crucial role in addressing pet owners' concerns and addressing any misconceptions about vaccines. Additionally, transparency in vaccine development, testing, and regulatory approval processes can help build trust and confidence among pet owners.

Price Sensitivity Among Consumers

The high cost associated with vaccine development and distribution poses a significant challenge to the global dog vaccine market. Developing new vaccines requires substantial investment in research and development, clinical trials, and regulatory approval processes. Additionally, manufacturing and distributing vaccines to meet global demand incur significant costs. These high costs can result in limited access to vaccines, particularly in low-income or resource-constrained regions. Furthermore, the affordability of vaccines may be a barrier for some pet owners, especially in areas where veterinary services are not subsidized or covered by insurance.

Efforts to address the high cost of vaccine development and distribution may include incentivizing research and development through grants or funding, streamlining regulatory processes to reduce time and costs associated with vaccine approval, and exploring innovative approaches to vaccine manufacturing and distribution to improve cost-effectiveness.

Key Market Trends

Technological Advancements in Vaccine Development

Technological advancements in vaccine development are playing a pivotal role in boosting the global dog vaccine market. Over the years, significant strides have been made in veterinary medicine and biotechnology, leading to the development of more efficacious, safer, and innovative vaccines for dogs. These advancements are revolutionizing the landscape of dog vaccination and contributing to the expansion of the global market.

One of the key technological advancements in vaccine development is the use of recombinant DNA technology. This approach allows scientists to genetically engineer vaccines by inserting genes encoding specific antigens into harmless carrier organisms or cell cultures. The resulting recombinant vaccines stimulate a targeted immune response in dogs, providing protection against specific diseases such as rabies, parvovirus, and distemper. Recombinant vaccines offer several advantages over traditional vaccines, including improved safety, efficacy, and ease of production.

Another significant technological advancement is the development of DNA vaccines for dogs. DNA vaccines work by introducing small pieces of DNA encoding antigens from pathogens into the dog's cells. Once inside the cells, the DNA is translated into protein antigens, triggering an immune response. DNA vaccines offer several benefits, including the ability to induce both cellular and humoral immunity, long-lasting protection, and ease of administration. They also have the potential to be rapidly developed and produced in response to emerging infectious diseases.

Furthermore, advances in vaccine delivery technologies are enhancing the effectiveness and convenience of dog vaccines. Novel delivery methods, such as oral vaccines and needle-free delivery systems, offer alternative routes of administration that are less stressful for dogs and easier for pet owners and veterinarians to administer. Oral vaccines, for example, can be delivered through food or water, eliminating the need for injections and reducing vaccine-associated stress in dogs. Needle-free delivery systems use devices that deliver vaccines through the skin using high-pressure jets or microneedles, minimizing pain and discomfort for dogs. Additionally, the application of adjuvants and vaccine formulations is being refined to enhance vaccine efficacy and safety. Adjuvants are substances added to vaccines to boost the immune response, improve antigen stability, and prolong vaccine duration.

Focus on Preventive Healthcare

The focus on preventive healthcare is significantly boosting the global dog vaccine market. Pet owners and veterinarians alike are increasingly recognizing the importance of preventive measures in ensuring the health and well-being of dogs. Preventive healthcare encompasses a range of proactive measures aimed at preventing diseases, detecting health issues early, and maintaining overall wellness in dogs. Among these measures, vaccination plays a central role in protecting dogs from infectious diseases.

Vaccination is a cornerstone of preventive healthcare for dogs, as it helps stimulate the dog's immune system to produce protective antibodies against specific diseases. By vaccinating dogs against common infectious diseases such as rabies, parvovirus, distemper, and canine influenza, pet owners can significantly reduce the risk of their dogs contracting these illnesses. Moreover, vaccination not only prevents disease in individual dogs but also helps control the spread of infectious diseases within the canine population.

The emphasis on preventive healthcare is driven by a growing understanding of the benefits of early intervention and disease prevention. Pet owners are increasingly proactive in seeking veterinary care for their dogs, including regular wellness check-ups and vaccination appointments. By taking a preventive approach to healthcare, pet owners can help ensure that their dogs lead longer, healthier lives, free from preventable diseases.

Furthermore, with the rise of the human-animal bond and the growing trend of pet humanization, pet owners are increasingly willing to invest in the health and well-being of their dogs. Many pet owners view their dogs as cherished members of the family and are committed to providing them with the best possible care. This includes preventive measures such as vaccination, which are seen as essential in safeguarding the health and happiness of their canine companions.

Veterinarians also play a crucial role in promoting preventive healthcare and vaccination among pet owners. Through education, outreach, and preventive care programs, veterinarians help raise awareness about the importance of vaccination and encourage pet owners to adhere to recommended vaccination schedules. By working collaboratively with pet owners, veterinarians can help ensure that dogs receive the necessary vaccinations to protect them from infectious diseases and maintain their overall health and well-being.

Segmental Insights

Disease Type Insights

Based on the disease type, canine infectious respiratory disease complex (CIRDC) segment emerged as the dominant segment in the global dog vaccine market in 2023. Canine infectious respiratory disease complex (CIRDC), also known as kennel cough, is a highly contagious respiratory infection that affects dogs of all ages and breeds. The prevalence of CIRDC is widespread, particularly in environments where dogs are near one another, such as boarding facilities, dog parks, and shelters. The contagious nature of CIRDC and the ease with which it spreads among dogs have heightened concerns among pet owners and veterinarians, driving the demand for vaccines to protect against this respiratory disease.

Component Insights

Based on the component, combined vaccine segment emerged as the dominant segment in the global dog vaccine market in 2023. Combined vaccines, also known as multivalent or polyvalent vaccines, offer protection against multiple diseases with a single injection. These vaccines typically contain antigens from several pathogens, providing immunity against a range of infectious diseases in dogs. The convenience and efficiency of combined vaccines make them an attractive option for pet owners and veterinarians seeking comprehensive protection for their dogs against various diseases. Additionally, one of the primary reasons for the dominance of the combined vaccine segment is the growing recognition of the importance of preventive healthcare in dogs.

Regional Insights

North America emerged as the dominant region in the global dog vaccine market in 2023, holding the largest market share. North America boasts a large and well-established pet population, with a significant portion of households owning dogs as beloved companions. The region's high pet ownership rates translate into a sizable market for pet healthcare products and services, including vaccines. Pet owners in North America are often proactive in seeking veterinary care for their dogs and prioritizing preventive measures such as vaccination to ensure their pets' health and well-being.

Key Market Players

Bioveta A.S

Hester Biosciences Limited

Boehringer Ingelheim International GmbH

Brilliant Bio Pharma Private Limited

Heska Corporation

Merck & Co., Inc.

Virbac SACA

Zendal Group

Elanco Animal Health Inc.

Zoetis Services LLC

Report Scope:

In this report, the Global Dog Vaccine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Dog Vaccine Market, By Type:

    Modified/ Attenuated Live Inactivated (Killed) Others

Dog Vaccine Market, By Disease Type:

    Canine Distemper Canine Infectious Respiratory Disease Complex (CIRDC) Canine Parvovirosis/Parvovirus Disease Canine Leptospirosis Canine Lyme Disease Infectious Canine Hepatitis Canine Rabies Other Diseases

Dog Vaccine Market, By Route of Administration:

    Injectable Intranasal Oral

Dog Vaccine Market, By Component:

    Combined Vaccines Mono Vaccines

Dog Vaccine Market, By Region:

    North America

United States

Canada

Mexico

    Europe

France

United Kingdom

Italy

Germany

Spain

    Asia-Pacific

China

India

Japan

Australia

South Korea

    South America

Brazil

Argentina

Colombia

    Middle East & Africa

South Africa

Saudi Arabia

UAE

Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Dog Vaccine Market.

Available Customizations:

Global Dog Vaccine Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Dog Vaccine Market Outlook

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share & Forecast
    • 4.2.1. By Type (Modified/ Attenuated Live, Inactivated (Killed), Others)
    • 4.2.2. By Disease Type (Canine Distemper, Canine Infectious Respiratory Disease Complex (CIRDC), Canine Parvovirosis/ Parvovirus Disease, Canine Leptospirosis, Canine Lyme Disease, Infectious Canine Hepatitis, Canine Rabies, Other Diseases)
    • 4.2.3. By Route of Administration (Injectable, Intranasal, Oral)
    • 4.2.4. By Component (Combined Vaccines, Mono Vaccines)
    • 4.2.5. By Region
    • 4.2.6. By Company (2023)
  • 4.3. Market Map
    • 4.3.1. By Type
    • 4.3.2. By Disease Type
    • 4.3.3. By Route of Administration
    • 4.3.4. By Component
    • 4.3.5. By Region

5. Asia Pacific Dog Vaccine Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type
    • 5.2.2. By Disease Type
    • 5.2.3. By Route of Administration
    • 5.2.4. By Component
    • 5.2.5. By Country
  • 5.3. Asia Pacific: Country Analysis
    • 5.3.1. China Dog Vaccine Market Outlook
      • 5.3.1.1. Market Size & Forecast
        • 5.3.1.1.1. By Value
      • 5.3.1.2. Market Share & Forecast
        • 5.3.1.2.1. By Type
        • 5.3.1.2.2. By Disease Type
        • 5.3.1.2.3. By Route of Administration
        • 5.3.1.2.4. By Component
    • 5.3.2. India Dog Vaccine Market Outlook
      • 5.3.2.1. Market Size & Forecast
        • 5.3.2.1.1. By Value
      • 5.3.2.2. Market Share & Forecast
        • 5.3.2.2.1. By Type
        • 5.3.2.2.2. By Disease Type
        • 5.3.2.2.3. By Route of Administration
        • 5.3.2.2.4. By Component
    • 5.3.3. Australia Dog Vaccine Market Outlook
      • 5.3.3.1. Market Size & Forecast
        • 5.3.3.1.1. By Value
      • 5.3.3.2. Market Share & Forecast
        • 5.3.3.2.1. By Type
        • 5.3.3.2.2. By Disease Type
        • 5.3.3.2.3. By Route of Administration
        • 5.3.3.2.4. By Component
    • 5.3.4. Japan Dog Vaccine Market Outlook
      • 5.3.4.1. Market Size & Forecast
        • 5.3.4.1.1. By Value
      • 5.3.4.2. Market Share & Forecast
        • 5.3.4.2.1. By Type
        • 5.3.4.2.2. By Disease Type
        • 5.3.4.2.3. By Route of Administration
        • 5.3.4.2.4. By Component
    • 5.3.5. South Korea Dog Vaccine Market Outlook
      • 5.3.5.1. Market Size & Forecast
        • 5.3.5.1.1. By Value
      • 5.3.5.2. Market Share & Forecast
        • 5.3.5.2.1. By Type
        • 5.3.5.2.2. By Disease Type
        • 5.3.5.2.3. By Route of Administration
        • 5.3.5.2.4. By Component

6. Europe Dog Vaccine Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Disease Type
    • 6.2.3. By Route of Administration
    • 6.2.4. By Component
    • 6.2.5. By Country
  • 6.3. Europe: Country Analysis
    • 6.3.1. France Dog Vaccine Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Disease Type
        • 6.3.1.2.3. By Route of Administration
        • 6.3.1.2.4. By Component
    • 6.3.2. Germany Dog Vaccine Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Disease Type
        • 6.3.2.2.3. By Route of Administration
        • 6.3.2.2.4. By Component
    • 6.3.3. Spain Dog Vaccine Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Disease Type
        • 6.3.3.2.3. By Route of Administration
        • 6.3.3.2.4. By Component
    • 6.3.4. Italy Dog Vaccine Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Type
        • 6.3.4.2.2. By Disease Type
        • 6.3.4.2.3. By Route of Administration
        • 6.3.4.2.4. By Component
    • 6.3.5. United Kingdom Dog Vaccine Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Type
        • 6.3.5.2.2. By Disease Type
        • 6.3.5.2.3. By Route of Administration
        • 6.3.5.2.4. By Component

7. North America Dog Vaccine Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Disease Type
    • 7.2.3. By Route of Administration
    • 7.2.4. By Component
    • 7.2.5. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Dog Vaccine Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Disease Type
        • 7.3.1.2.3. By Route of Administration
        • 7.3.1.2.4. By Component
    • 7.3.2. Mexico Dog Vaccine Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Disease Type
        • 7.3.2.2.3. By Route of Administration
        • 7.3.2.2.4. By Component
    • 7.3.3. Canada Dog Vaccine Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Disease Type
        • 7.3.3.2.3. By Route of Administration
        • 7.3.3.2.4. By Component

8. South America Dog Vaccine Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Disease Type
    • 8.2.3. By Route of Administration
    • 8.2.4. By Component
    • 8.2.5. By Country
  • 8.3. South America: Country Analysis
    • 8.3.1. Brazil Dog Vaccine Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Disease Type
        • 8.3.1.2.3. By Route of Administration
        • 8.3.1.2.4. By Component
    • 8.3.2. Argentina Dog Vaccine Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Disease Type
        • 8.3.2.2.3. By Route of Administration
        • 8.3.2.2.4. By Component
    • 8.3.3. Colombia Dog Vaccine Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Disease Type
        • 8.3.3.2.3. By Route of Administration
        • 8.3.3.2.4. By Component

9. Middle East and Africa Dog Vaccine Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Disease Type
    • 9.2.3. By Route of Administration
    • 9.2.4. By Component
    • 9.2.5. By Country
  • 9.3. MEA: Country Analysis
    • 9.3.1. South Africa Dog Vaccine Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Disease Type
        • 9.3.1.2.3. By Route of Administration
        • 9.3.1.2.4. By Component
    • 9.3.2. Saudi Arabia Dog Vaccine Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Disease Type
        • 9.3.2.2.3. By Route of Administration
        • 9.3.2.2.4. By Component
    • 9.3.3. UAE Dog Vaccine Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Disease Type
        • 9.3.3.2.3. By Route of Administration
        • 9.3.3.2.4. By Component
    • 9.3.4. Egypt Dog Vaccine Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Type
        • 9.3.4.2.2. By Disease Type
        • 9.3.4.2.3. By Route of Administration
        • 9.3.4.2.4. By Component

10. Market Dynamics

  • 10.1. Drivers
  • 10.2. Challenges

11. Market Trends & Developments

  • 11.1. Recent Developments
  • 11.2. Product Launches
  • 11.3. Mergers & Acquisitions

12. Global Dog Vaccine Market: SWOT Analysis

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Product

14. Competitive Landscape

  • 14.1. Bioveta A.S
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As Reported)
    • 14.1.5. Recent Developments
    • 14.1.6. Key Personnel Details
    • 14.1.7. SWOT Analysis
  • 14.2. Hester Biosciences Limited
  • 14.3. Boehringer Ingelheim International GmbH
  • 14.4. Brilliant Bio Pharma Private Limited
  • 14.5. Heska Corporation
  • 14.6. Merck & Co., Inc.
  • 14.7. Virbac SACA
  • 14.8. Zendal Group
  • 14.9. Elanco Animal Health Inc
  • 14.10. Zoetis Services LLC.

15. Strategic Recommendations

16. About Us & Disclaimer